Form 8-K - Current report:
SEC Accession No. 0001193125-10-267601
Filing Date
2010-11-23
Accepted
2010-11-23 16:22:59
Documents
1
Period of Report
2010-11-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14929
  Complete submission text file 0001193125-10-267601.txt   16660
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 101211983
SIC: 2835 In Vitro & In Vivo Diagnostic Substances